Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report)'s stock price was down 3.6% during mid-day trading on Tuesday . The stock traded as low as $5.66 and last traded at $5.69. Approximately 6,093,962 shares traded hands during trading, an increase of 32% from the average daily volume of 4,600,414 shares. The stock had previously closed at $5.90.
Analyst Ratings Changes
Several research analysts have recently issued reports on TLRY shares. Weiss Ratings raised Tilray Brands from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday, April 29th. Zacks Research raised shares of Tilray Brands from a "strong sell" rating to a "hold" rating in a research note on Wednesday, February 11th. TD Cowen cut their target price on shares of Tilray Brands from $10.00 to $7.00 and set a "buy" rating for the company in a research note on Monday, March 30th. ATB Cormark Capital Markets cut their target price on shares of Tilray Brands from $9.50 to $9.00 and set a "sector perform" rating for the company in a research note on Thursday, April 2nd. Finally, Canaccord Genuity Group assumed coverage on shares of Tilray Brands in a research note on Tuesday, January 27th. They issued a "hold" rating for the company. Three analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $11.50.
Get Our Latest Stock Report on Tilray Brands
Tilray Brands Stock Down 3.6%
The firm's 50 day moving average is $6.92 and its two-hundred day moving average is $9.02. The stock has a market cap of $663.16 million, a price-to-earnings ratio of -0.42 and a beta of 1.94. The company has a current ratio of 2.79, a quick ratio of 1.66 and a debt-to-equity ratio of 0.19.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last announced its earnings results on Wednesday, April 1st. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.10). Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. The firm had revenue of $206.73 million during the quarter, compared to analyst estimates of $201.35 million. During the same period in the previous year, the firm posted ($0.87) EPS. On average, sell-side analysts predict that Tilray Brands, Inc. will post -0.58 EPS for the current year.
Insiders Place Their Bets
In related news, Director David G. Hopkinson sold 33,556 shares of the business's stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $6.94, for a total value of $232,878.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.84% of the company's stock.
Institutional Trading of Tilray Brands
Several hedge funds and other institutional investors have recently added to or reduced their stakes in TLRY. Tidal Investments LLC grew its holdings in Tilray Brands by 15.0% in the 2nd quarter. Tidal Investments LLC now owns 28,971,835 shares of the company's stock valued at $12,006,000 after buying an additional 3,776,410 shares during the period. Millennium Management LLC grew its holdings in Tilray Brands by 281.0% in the 3rd quarter. Millennium Management LLC now owns 4,942,319 shares of the company's stock valued at $8,550,000 after buying an additional 3,645,060 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Tilray Brands in the 3rd quarter valued at about $5,813,000. Ausdal Financial Partners Inc. purchased a new stake in Tilray Brands in the 2nd quarter valued at about $939,000. Finally, Scientech Research LLC purchased a new stake in Tilray Brands in the 3rd quarter valued at about $1,748,000. Hedge funds and other institutional investors own 9.35% of the company's stock.
About Tilray Brands
(
Get Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.